Evidence map›Paper›PMID 29442223›Full record

ArticleStem cell reviews and reports2018

Beneficial Role of Low-Intensity Laser Irradiation on Neural β-tubulin III Protein Expression in Human Bone Marrow Multipotent Mesenchymal Stromal Cells.

Valéria Ferreira-Silva, Fernando L Primo, Munira M A Baqui, Danielle A R Magalhães, Maristela D Orellana, Andrielle Castilho-Fernandes, Mario C Cruz, Niehls O S Câmara, Dimas T Covas, Antonio C Tedesco

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Stem cell reviews and reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Valéria Ferreira-SilvaDepartment of Chemistry, Centre of Nanotechnology and Tissue Engineering-Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto, University of São Paulo, Ribeirão Preto, 14040-901, Brazil.
Fernando L PrimoDepartment of Bioprocess and Biotechnology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, 14800-903, SP, Brazil.
Munira M A BaquiDepartment of Cell and Molecular Biology and Pathogenic Bioagents, Medical School, University of São Paulo, Ribeirão Preto, 14049-900, Brazil.
Danielle A R MagalhãesCentre for Cell Therapy and Regional Blood Centre, National Institute of Science and Technology in Stem Cell and Cell Therapy, Medical School, University of São Paulo, Ribeirão Preto, 14051-140, Brazil.
Maristela D OrellanaCentre for Cell Therapy and Regional Blood Centre, National Institute of Science and Technology in Stem Cell and Cell Therapy, Medical School, University of São Paulo, Ribeirão Preto, 14051-140, Brazil.
Andrielle Castilho-FernandesDepartment of Chemistry, Centre of Nanotechnology and Tissue Engineering-Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto, University of São Paulo, Ribeirão Preto, 14040-901, Brazil.
Mario C CruzInstitute of Biomedical Science, Department of Immunology, University of São Paulo, São Paulo, 05508-900, Brazil.
Niehls O S CâmaraInstitute of Biomedical Science, Department of Immunology, University of São Paulo, São Paulo, 05508-900, Brazil.
Dimas T CovasCentre for Cell Therapy and Regional Blood Centre, National Institute of Science and Technology in Stem Cell and Cell Therapy, Medical School, University of São Paulo, Ribeirão Preto, 14051-140, Brazil.
Antonio C TedescoDepartment of Chemistry, Centre of Nanotechnology and Tissue Engineering-Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto, University of São Paulo, Ribeirão Preto, 14040-901, Brazil. atedesco@usp.br.
Universidade de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) INCT 472423/2013-4FINEP 01.10.0758.01Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2013/50181-1
6 · The paper itself

Abstract

The purpose of the present study was to evaluate the neural protein expression pattern of human multipotent mesenchymal stromal cells (hMSCs) treated with forskolin (free-form/FF). The study investigated forskolin's capacity to enhance intracellular levels of cyclic adenosine monophosphate (cAMP) by activating adenylate cyclase and probably by inducing neuron-like cells in vitro. In addition, because nanotechnology is a growing field of tissue engineering, we also assessed the action of a new system called the nanostructured-forskolin (NF) to examine the improvement of drug delivery. Afterwards, the cells were submitted to low-level laser irradiation to evaluate possible photobiostimulatory effects. Investigations using the immunofluorescence by confocal microscopy and Western blot methods revealed the expression of the neuronal marker β-tubulin III. Fluorescence intensity quantification analysis using INCell Analyzer System for β-tubulin III was used to examine significant differences. The results showed that after low-level laser irradiation exposure, there was a tendency to increase the β-tubulin III expression in all groups, as expected in the photobiostimulation process. Notably, this process induced for irradiation was more pronounced in irradiated nanoforskolin cells (INF) compared to non-irradiated free-forskolin control cells (NFFC). However, there was also an increase in β-tubulin III protein expression in the groups: irradiated nanocontrol cells (INC) compared to non-irradiated free-forskolin control cells (NFF) and after treatment with non-irradiated free-forskolin (NFF) and non-irradiated nanoforskolin (NNFC). We concluded that the methods using low-level laser irradiation and/or nanoparticles showed an up-regulation of neural-protein expression in hMSCs that could be used to facilitate cellular therapy protocols in the near future.

Indexed as

LasersBone Marrow CellsCell DifferentiationCells, CulturedColforsinDose-Response Relationship, RadiationHumansMesenchymal Stem CellsNeuronsTubulinVasodilator AgentsColforsinTubulinVasodilator AgentsForskolinLow-intensity laser irradiationMultipotent mesenchymal stromal cellsNano-drug deliveryNanotechnologyβ-Tubulin III

Identifiers

PMID29442223
OpenAlexW2788644194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.